IM 250
Alternative Names: IM-250Latest Information Update: 28 Aug 2025
At a glance
- Originator Innovative Molecules
- Class Amides; Antivirals; Fluorobenzenes; Small molecules; Sulfides; Sulfones; Thiazoles; Toluenes
- Mechanism of Action DNA helicase-primase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Herpes genitalis
- Phase I Herpes simplex virus infections
Most Recent Events
- 27 Jun 2025 Innovative Molecules terminates phase I trial (In volunteers) in Bulgaria, due to sponsor decision (EUCT2024-519482-22-00)
- 30 Apr 2025 Innovative Molecules initiates phase I trial (In volunteers) in Bulgaria (EUCT2024-519482-22-00)
- 19 Apr 2025 Innovative Molecules plans to initiate a phase I trial in healthy volunteers in Bulgaria (PO) (CTIS2024-518155-37-00)